Director, Strategic Biopharma Business Dev
Phenomenex
Torrance, California
John C Gebler PhD, Directory, Strategic Biopharma Business Development, Phenomenex.
Work with Phenomenex and Danaher leadership to create and manage a biopharma separations and sample prep consumables growth vision. Mange the execution of biopharma roadmap with Phenomenex innovation, marketing, and sales partners. Meet with scientists from pharmaceutical and biotech industry developing concepts for future biopharma products, applications, and methods. Manage high-level collaborations with industry and academics.
From 2001- 2021, Director, Waters Corporation, Milford, MA. Biopharmaceutical Business Development. Responsible to develop Waters biopharmaceutical LC/MS business and strategy worldwide. Promoted technology through presentations, training, and social media outlets. Managed collaborations with thought-leaders on LC/MS in academics and thought leader programs. Directed the development of applications, methods, and technologies for high performance routine characterization of biopolymers (peptides, proteins, antibodies, oligonucleotides, and glycans).
From1992–2001, Principal Scientist Abbott Laboratories, Abbott Diagnostic Division. Developed LC/MS methods for the characterization of reagents (labeled proteins and antibodies, and low molecular weight labels) used for diagnostic products.
Received PhD from the Universitoy of Utah in from the department of chemistry and was a Postdoctoral Fellow-research at the University of British Columbia, Department of Chemistry.
Author/coauthor on 65 peer-reviewed publications
Disclosure information not submitted.
Tuesday, October 18, 2022
9:30 AM – 10:30 AM ET